Hemoglobin is a protein inside red blood cells that carries oxygen throughout the body. A hemoglobin test (Hb, Hgb) reveals the level of hemoglobin in a person’s blood, helping to diagnose and monitor anemia and polycythemia vera. A Hemoglobin A1c test is an important measure of how well a person with diabetes is controlling their blood glucose level. Hemoglobin A1c test reflects the average blood sugar level of an individual for the past two to three months, which is then used for diabetes management. Rising awareness, higher incidence and prevalence of diabetes and aging of population are significantly contributing to the growth of the hemoglobin A1c testing devices market.
The global hemoglobin testing devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global hemoglobin testing devices market segmentation is based on technologies (boronate affinity chromatography, direct enzymatic assay, immunoassay, ion-exchange HPLC, micro-optical detection method, capillary electrophoresis) and end users (laboratory testing devices, point-of-care testing devices).
The global hemoglobin testing devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global hemoglobin testing devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global hemoglobin testing devices market and included in this report are Abbott Laboratories, Alere, Inc., Arkray, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., A. Menarini Diagnostics, F. Hoffmann-La Roche Ltd. and Siemens Healthcare.